1800 202 8726
Reading your scan report

'Metabolically Active Disease': — What Your PET-CT Report Is Saying

You found this phrase in a report and are reading it before your next appointment. It is a PET-CT term describing how hard cells in a particular area are working — not a verdict, and not the last word. Your oncologist interprets it in the full context of your case.

Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed September 2026

  • A PET-CT finding, not a diagnosis — The phrase describes what the scan measured. A diagnosis requires your full history and, often, tissue from a biopsy.
  • Measures activity, not just size — CT shows the shape of an area. PET-CT shows how much glucose the cells there are using. They answer different questions.
  • It can appear in different situations — You may see it at initial staging, during treatment, or in a follow-up scan. The meaning differs in each context.
  • Your oncologist reads the full report — The phrase is one part of a longer document, and your oncologist interprets the whole picture together.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Get this explained properly

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

'Metabolically active disease' is a PET-CT term meaning an area of your body is taking up glucose faster than the surrounding tissue. Cancer cells typically do this. The phrase describes what the scan observed — not your prognosis or your treatment plan. Your oncologist interprets this finding alongside your history, biopsy results, and other investigations.

What does 'metabolically active disease' mean?

PET stands for positron emission tomography. Before the scan, you are given a glucose tracer. Areas of your body that use a lot of glucose absorb more of the tracer and show as brighter spots on the image.

When a radiologist writes 'metabolically active disease', they are describing an area where cells are using glucose at a higher-than-normal rate. Cancer cells tend to do this. So does inflamed tissue, and so do some normal organs.

The radiologist describes what the scan shows. They do not have your full history in front of them. Your oncologist reads the report alongside everything else before deciding what the finding means for you.

Terms you will see in the same report

PET-CT
A scan that combines a positron emission tomography image — which measures glucose uptake — with a CT image, which shows anatomy. The two together let the radiologist say where a finding is and how metabolically active it is at the same time.
FDG (fluorodeoxyglucose)
The radioactive glucose tracer injected before the scan. Cells that use a lot of glucose take up more FDG and appear brighter on the image. Cancer cells often do this, but so can inflammation, infection, and some normal tissues such as the brain and heart.
SUV (Standardised Uptake Value)
A number the scanner calculates to express how much tracer a specific area absorbed. A higher number means more activity. Your oncologist uses it to compare areas within the same scan and to track whether activity changes between scans over time.
FDG-avid
Another phrase for the same observation. 'FDG-avid disease' and 'metabolically active disease' mean the same thing — the area is absorbing the glucose tracer at a higher rate. You may see either phrase, or both, in the same report.

Still unclear?

Send your reports across and a specialist will walk you through what they mean — what is known, what is not, and what the options actually are.

PET-CT Partner Centres

PET-CT Scan Centres in Hyderabad

CION offers PET-CT scans through 4 trusted partner PET-CT centres across Hyderabad, so you can choose the one closest to you. Call 18002028726 and we’ll guide you to the earliest available appointment.

These are partner diagnostic centres within the CION network. Toll-free booking: 18002028726.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Get a straight answer from a specialist

45 minutes, your reports reviewed, your questions answered in plain language.

Book Free Consultation Call 1800 202 8726

Is metabolically active disease worse than finding a mass on CT?

CT and PET-CT answer different questions. A CT scan shows the shape and size of structures in your body. A PET-CT shows how much glucose those structures are using. Comparing the two as better or worse is like comparing the size of a fire with how hot it is burning — they are separate measurements.

An area can look like a significant mass on CT but show no metabolic activity at all. This is often scar tissue or treated disease that has gone quiet. An area can also be metabolically active but too small for CT to measure precisely.

Neither finding is automatically more or less serious than the other. Your oncologist reads both scans together. A concerning finding on one often needs the other to understand what it represents.

Questions families often ask after getting this result

Does it definitely mean cancer is there?

Not always. PET-CT alone cannot confirm a cancer diagnosis — that requires tissue, usually from a biopsy. Some non-cancerous conditions cause increased glucose uptake too, including active inflammation, infection, and certain benign tumours. The radiologist notes the finding; your oncologist and the full clinical picture determine what it represents. If there is genuine uncertainty, a biopsy or a follow-up scan is typically the next step your team will discuss.

Does metabolically active disease mean it has spread?

Not necessarily. Metabolic activity can be found in a primary tumour, in lymph nodes, or at distant sites — and the significance is different in each case. The location matters as much as the finding itself. Your oncologist will explain which areas were active, whether those locations are relevant to your staging, and what, if anything, it changes about your treatment plan.

What does 'no residual metabolic activity' mean?

This phrase appears in follow-up scans after treatment has been given. It means the areas that previously showed up bright on the PET-CT are now metabolically quiet — no significant glucose uptake is visible there any more. For many cancers, ASCO and ESMO guidance treats this as a positive marker of treatment response, though what it means for your ongoing care depends on your specific diagnosis and which treatment you received.

What happens next after this result?

Your oncologist reviews the full report alongside your history and any other investigations before deciding the next step. That might mean a biopsy to confirm what the activity represents, a staging discussion, a change to your treatment, or a comparison with your previous scan to assess response. The PET-CT report is an input into that conversation — it does not make the decision on its own, and neither can this page.

Book a PET-CT at CION from Rs 10,499 — among the lowest published prices in Hyderabad — with an oncologist-reviewed report and a free Rs 950 consultation, across 4 partner centres. Indicative price, as of September 2026.

Explore 94 more Understanding Your PET-CT Report topics

All Understanding Your PET-CT Report →

Your next step

Talk to an oncologist about your scan

Your PET-CT report read by a senior oncologist, explained in plain language, with a free 45-minute consultation.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

What does 'metabolically active disease' mean in plain English?

It means an area of your body is using glucose faster than the surrounding tissue. PET-CT scans detect glucose uptake, and cancer cells tend to use more glucose than normal cells. The phrase describes a finding on the scan — not a diagnosis and not a treatment decision. Your oncologist interprets what it means for your specific situation alongside your history and other results.

Is metabolically active disease serious?

The phrase describes an observation, not a prognosis. What it means depends on where the activity is, how much there is, your cancer type, and whether this is a first scan or a follow-up. Your oncologist cannot answer this from the phrase alone — and neither can a search result. The question to ask at your appointment is what this specific finding means in the context of your case.

Is it different from finding a tumour or a mass?

Yes. A mass on a CT report describes the visible size and shape of an area. 'Metabolically active disease' on a PET-CT describes how much glucose that area is using — a different measurement. The two findings often appear together. Sometimes one appears without the other. CT and PET-CT images are read alongside each other to build a complete picture.

What does the SUV number in my report mean?

SUV stands for Standardised Uptake Value — a number expressing how much of the glucose tracer a specific area absorbed. A higher number means more uptake. Your oncologist uses it to compare areas within the same scan and to track changes between scans. The number only has meaning in the context of your cancer type and your previous results — a single figure does not tell you on its own whether the finding is significant.

Does metabolically active disease mean my treatment is not working?

Not necessarily. The answer depends on whether this is a new finding or a response assessment, what your baseline scan showed, and how much activity remains compared with before treatment. For many cancers, a reduction in metabolic activity is a marker of treatment response, even when some activity is still visible. Your oncologist will compare this scan with your previous one and explain what any change means for your plan.

What should I ask my doctor when I go in?

Ask where the metabolic activity was found and whether it was present on your previous scan. Ask what the finding changes about your treatment. Ask whether a biopsy is needed to confirm what the activity represents. If any phrase in the report is unclear, ask for a plain-language explanation — that is a reasonable thing to expect at your appointment. Writing your questions down beforehand helps you cover them all in the time you have.

Call now Book free consultation